Global Gonadotropins Market 2023-2029

Global Gonadotropins Market 2023-2029

Gonadotropins are glycoprotein hormones secreted by gonadotropic cells of the anterior pituitary of vertebrates. Gonadotropins may improve the chances of becoming pregnant (with in vitro fertilization [IVF], intrauterine insemination [IUI], or by natural intercourse) by stimulating the ovaries to produce more than one follicle. The global gonadotropins market size is projected to grow by USD 2.0 billion from 2023 to 2029, registering a CAGR of 7.2 percent, according to the latest market data.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global gonadotropins market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the drug, application, end user, and region. The global market for gonadotropins can be segmented by drug: follitropin, menotropin, others. Among these, the follitropin segment was accounted for the highest revenue generator in 2022. Gonadotropins market is further segmented by application: male hypogonadism, treatment for female infertility, others. The treatment for female infertility segment is estimated to account for the largest share of the global gonadotropins market. Based on end user, the gonadotropins market is segmented into: male, female. The female segment held the largest share of the global gonadotropins market in 2022 and is anticipated to hold its share during the forecast period. On the basis of region, the gonadotropins market also can be divided into: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America. In 2022, North America made up the largest share of revenue generated by the gonadotropins market.

Market Segmentation
By drug: follitropin, menotropin, others
By application: male hypogonadism, treatment for female infertility, others
By end user: male, female
By region: North America, Europe, Asia-Pacific, MEA (Middle East and Africa), Latin America

The report has also analysed the competitive landscape of the global gonadotropins market with some of the key players being AbbVie Inc., Ferring BV, Fresenius SE & Co. KGaA, IBSA Institut Biochimique SA, Intas Pharmaceuticals Limited, Lupin Limited, Merck KGaA, Serum Institute of India Pvt. Ltd, Sun Pharmaceutical Industries Ltd., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.

Scope of the Report

• To analyze and forecast the market size of the global gonadotropins market.
• To classify and forecast the global gonadotropins market based on drug, application, end user, region.
• To identify drivers and challenges for the global gonadotropins market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global gonadotropins market.
• To identify and analyze the profile of leading players operating in the global gonadotropins market.


Why Choose This Report
• Gain a reliable outlook of the global gonadotropins market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.